Search research articles
Contact Us
Filters
Showing results (441-450 of 489) with videos related to
Page
of 49
Sort By:
Placenta
|
October 18, 2005
Three-dimensional growth of extravillous cytotrophoblasts promotes differentiation and invasion
H L LaMarca, C M Ott, K Höner Zu Bentrup, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 21, 2004
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America
Gregory J Mertz, Lil Miedzinski, Diane Goade, et al.
The Journal of Pediatrics
|
August 14, 2003
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial
David W Kimberlin, Chin-Yu Lin, Pablo J Sánchez, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 23, 2018
The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y<sub>12</sub> inhibition
M J Whitley, D M Henke, A Ghazi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 22, 2009
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system
Sara E Oliver, Gretchen A Cloud, Pablo J Sánchez, et al.
Physics in Medicine and Biology
|
October 21, 2005
Dynamic imaging of the lungs using x-ray phase contrast
R A Lewis, N Yagi, M J Kitchen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 30, 2008
Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM
James M Markert, Peter G Liechty, Wenquan Wang, et al.
Oncogene
|
July 11, 2019
Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance
Stacie K Totsch, Charles Schlappi, Kyung-Don Kang, et al.
The Journal of Infectious Diseases
|
February 19, 2008
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease
David W Kimberlin, Edward P Acosta, Pablo J Sánchez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 3, 2024
A randomized, placebo-controlled, dose-escalation phase I/II multicenter trial of low-dose cidofovir for BK polyomavirus nephropathy
Hannah Imlay, John W Gnann, James Rooney, et al.
Page
of 49
Search research articles
Search
Showing results (441-450 of 489) with videos related to
Sort By:
Page
of 49
Placenta
|
October 18, 2005
Three-dimensional growth of extravillous cytotrophoblasts promotes differentiation and invasion
H L LaMarca, C M Ott, K Höner Zu Bentrup, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 21, 2004
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America
Gregory J Mertz, Lil Miedzinski, Diane Goade, et al.
The Journal of Pediatrics
|
August 14, 2003
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial
David W Kimberlin, Chin-Yu Lin, Pablo J Sánchez, et al.
Journal of Thrombosis and Haemostasis : JTH
|
October 23, 2018
The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y<sub>12</sub> inhibition
M J Whitley, D M Henke, A Ghazi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 22, 2009
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system
Sara E Oliver, Gretchen A Cloud, Pablo J Sánchez, et al.
Physics in Medicine and Biology
|
October 21, 2005
Dynamic imaging of the lungs using x-ray phase contrast
R A Lewis, N Yagi, M J Kitchen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 30, 2008
Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM
James M Markert, Peter G Liechty, Wenquan Wang, et al.
Oncogene
|
July 11, 2019
Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance
Stacie K Totsch, Charles Schlappi, Kyung-Don Kang, et al.
The Journal of Infectious Diseases
|
February 19, 2008
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease
David W Kimberlin, Edward P Acosta, Pablo J Sánchez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 3, 2024
A randomized, placebo-controlled, dose-escalation phase I/II multicenter trial of low-dose cidofovir for BK polyomavirus nephropathy
Hannah Imlay, John W Gnann, James Rooney, et al.
Page
of 49